NCT05595720

Brief Summary

Hemiplegic shoulder pain (HSP) is a common and disabling complication following a stroke, and it may affect the quality of life. It often occurs following two to three months of stroke. Upper limb impairment is seen in 90% of patients affected by stroke. Numerous causes have been implicated in developing HSP in stroke. This includes muscle flaccidity around the shoulder joint, shoulder subluxation, shoulder-hand syndrome, increased muscle tone, impingement syndrome, frozen shoulder, brachial plexus injury, and the thalamic syndrome. Muscle paresis, abnormal muscle tone and loss of proprioception following stroke may render the shoulder complex unstable and therefore prone to misalignment. In recent years, high-intensity laser therapy (HILT) has been considered as a treatment option for shoulder pain. HILT increases microcirculation and tissue regeneration and lowers edema, inflammation, and pain with its photomechanical, thermal, electrical, and bio stimulating effects in deep tissues that cannot be reached with LILT. It has some advantages over LILT, i.e., having higher power, greater tissue penetration capacity to deep tissues, the short emission time, and long rest periods preventing heat accumulation. In recent studies, effectiveness of HILT has been shown in the treatment of subacromial impingement syndrome, rotator cuff tendinopathy, and frozen shoulder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P50-P75 for phase_1 stroke

Timeline
Completed

Started Oct 2022

Shorter than P25 for phase_1 stroke

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 17, 2022

Completed
3 days until next milestone

Study Start

First participant enrolled

October 20, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

October 27, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 18, 2023

Completed
2 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 20, 2023

Completed
Last Updated

September 26, 2023

Status Verified

September 1, 2023

Enrollment Period

3 months

First QC Date

October 17, 2022

Last Update Submit

September 24, 2023

Conditions

Keywords

Stroke,Shoulder dysfunctionHigh intensity laser

Outcome Measures

Primary Outcomes (2)

  • PAIN score

    McGill pain questioner scale, scoring from zero to 78 zero is the best score seventy eight is the worst score

    1 MONTH

  • FUNCTION

    UCLA shoulder score from zero to 35 zero is the worst 35 is the best

    1 MONTH

Study Arms (2)

treatment group

EXPERIMENTAL
Device: hight intenisty laser

control group

NO INTERVENTION

Interventions

7W(LAZR-207)/15W(LAZR-215\&115)HIGH POWER LASER THERAPYUNIT WITH 2 WAVELENGTHMODES,COMBINATION(810+980 NM) AND SINGLE(1064 NM)

treatment group

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • DISORDER MORE THAN 6 MONTHS
  • UNILATERAL
  • FIRST TIME

You may not qualify if:

  • Iinflammatory rheumatic disease,
  • cervical radiculopathy,
  • diabetes mellitus,
  • thyroid disease,
  • coronary heart disease,
  • cardiac pacemaker,
  • neurological disease,
  • shoulder surgery, and
  • shoulder injection in the last 3 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Physical Therapy

Minya, Minya Governorate, 05673, Egypt

Location

MeSH Terms

Conditions

StrokeShoulder DislocationJoint Dislocations

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesJoint DiseasesMusculoskeletal DiseasesWounds and InjuriesShoulder Injuries

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 17, 2022

First Posted

October 27, 2022

Study Start

October 20, 2022

Primary Completion

January 18, 2023

Study Completion

January 20, 2023

Last Updated

September 26, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will share

Locations